SBP-3246 is primarily used in research settings as a selective modulator of specific cellular pathways involved in inflammatory and immune responses. It has shown potential in preclinical studies for targeting signaling proteins associated with chronic inflammation and autoimmune conditions. Due to its ability to cross cell membranes efficiently, it is utilized in cellular assays to study pathway inhibition and downstream effects on cytokine production. Its high selectivity makes it a valuable tool compound for validating therapeutic targets in drug discovery programs, particularly in immunology and oncology-related research. It is not intended for clinical use or human therapeutics at this stage.